Teladoc Health, Inc. (NYSE:TDOC) Given Average Recommendation of “Hold” by Analysts

Teladoc Health, Inc. (NYSE:TDOCGet Free Report) has been assigned a consensus recommendation of “Hold” from the eighteen analysts that are covering the firm, MarketBeat reports. Twelve investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $18.22.

Several analysts have weighed in on TDOC shares. Royal Bank of Canada dropped their target price on shares of Teladoc Health from $25.00 to $18.00 and set an “outperform” rating on the stock in a research report on Friday, April 26th. Canaccord Genuity Group dropped their target price on shares of Teladoc Health from $28.00 to $25.00 and set a “buy” rating on the stock in a research report on Friday, April 26th. SVB Leerink initiated coverage on shares of Teladoc Health in a report on Monday, February 26th. They issued a “market perform” rating and a $17.00 price objective on the stock. Wells Fargo & Company dropped their price objective on shares of Teladoc Health from $17.00 to $15.00 and set an “equal weight” rating on the stock in a report on Monday, April 29th. Finally, Oppenheimer dropped their price objective on shares of Teladoc Health from $26.00 to $21.00 and set an “outperform” rating on the stock in a report on Friday, April 26th.

Check Out Our Latest Analysis on Teladoc Health

Teladoc Health Trading Up 0.6 %

NYSE TDOC opened at $9.71 on Friday. The firm has a market cap of $1.65 billion, a PE ratio of -6.89 and a beta of 0.99. Teladoc Health has a 52 week low of $9.59 and a 52 week high of $30.41. The company has a quick ratio of 3.74, a current ratio of 3.82 and a debt-to-equity ratio of 0.67. The company has a 50 day moving average price of $11.89 and a 200 day moving average price of $16.06.

Teladoc Health (NYSE:TDOCGet Free Report) last released its earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The company had revenue of $646.13 million for the quarter, compared to analysts’ expectations of $637.31 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.37) EPS. As a group, sell-side analysts forecast that Teladoc Health will post -1.05 EPS for the current fiscal year.

Insiders Place Their Bets

In other Teladoc Health news, insider Laizer Kornwasser sold 10,411 shares of the company’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total transaction of $132,115.59. Following the completion of the transaction, the insider now directly owns 86,070 shares in the company, valued at $1,092,228.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Teladoc Health news, insider Arnnon Geshuri sold 7,500 shares of the company’s stock in a transaction on Monday, March 25th. The shares were sold at an average price of $15.06, for a total transaction of $112,950.00. Following the completion of the transaction, the insider now directly owns 38,470 shares in the company, valued at $579,358.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Laizer Kornwasser sold 10,411 shares of the stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total transaction of $132,115.59. Following the completion of the sale, the insider now owns 86,070 shares of the company’s stock, valued at $1,092,228.30. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 39,650 shares of company stock worth $505,863. Company insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

A number of hedge funds have recently modified their holdings of TDOC. Vanguard Group Inc. raised its position in shares of Teladoc Health by 11.8% in the fourth quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock valued at $377,451,000 after buying an additional 1,855,480 shares during the last quarter. ARK Investment Management LLC raised its position in shares of Teladoc Health by 4.5% in the fourth quarter. ARK Investment Management LLC now owns 21,224,565 shares of the health services provider’s stock valued at $457,389,000 after buying an additional 912,692 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of Teladoc Health by 25.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider’s stock valued at $82,636,000 after buying an additional 767,999 shares during the last quarter. Norges Bank acquired a new stake in shares of Teladoc Health in the fourth quarter valued at about $9,714,000. Finally, Charles Schwab Investment Management Inc. raised its position in shares of Teladoc Health by 37.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,549,585 shares of the health services provider’s stock valued at $28,807,000 after buying an additional 418,909 shares during the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Company Profile

(Get Free Report

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Read More

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.